Washington State

Athira’s Small Molecule Injection for Alzheimer’s Flops in Phase II/III Study

The investigational injection fosgonimeton appeared to have better efficacy in patients with more severe disease, according to post-hoc subgroup analyses, though none resulted in statistically significant effects.

September 4, 2024

2 min read

Tristan Manalac

PRESS RELEASES

Press Releases

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

January 23, 2026

1 min read

Press Releases

Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis

January 23, 2026

2 min read

Press Releases

60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria Prevention

January 23, 2026

8 min read

Press Releases

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

January 20, 2026

3 min read

Press Releases

Professor Sarfaraz Niazi’s Scientific Framework Adopted as FDA Modernizes Clinical Trial Evaluation Through Bayesian Methods

January 20, 2026

4 min read

Press Releases

Atossa Therapeutics Receives FDA Orphan Drug Designation for (Z)-Endoxifen for the Treatment of Duchenne Muscular Dystrophy

January 19, 2026

5 min read

Press Releases

Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform

January 19, 2026

3 min read

Press Releases

60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio

January 16, 2026

6 min read

Press Releases

LUNGevity and Rising Tide Foundation Issue RFA Tackling Lung Cancer’s Toughest Challenges: Drug Resistance and Cancer Recurrence

January 16, 2026

5 min read

Press Releases

LUNGevity Now Accepting Research Grant Applications to Drive Breakthroughs in Lung Cancer

January 16, 2026

4 min read

Press Releases

Center for Lyme Action Welcomes Meghan Bradshaw as New Executive Director

January 16, 2026

3 min read

Press Releases

Biokin to Present at J.P. Morgan’s 44th Annual Healthcare Conference

January 14, 2026

1 min read

Press Releases

Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery

January 13, 2026

4 min read

Press Releases

Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Spear Bio for the Transformative Bio-Hermes-002 Study

January 13, 2026

3 min read

Press Releases

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

January 13, 2026

6 min read

Press Releases

Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones

January 12, 2026

4 min read

Press Releases

Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results

January 12, 2026

4 min read

Press Releases

KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson’s Disease

January 12, 2026

3 min read

Press Releases

Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality

January 9, 2026

8 min read

Press Releases

Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA”

January 9, 2026

9 min read